title: Remission of recalcitrant dermatomyositis treated with ruxolitinib.
authors.affiliation: University of Bonn, Bonn, Germany.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Hornung
authors.forename: Viktor
authors.initials: V
authors.lastname: Janzen
authors.forename: Franz-Josef
authors.initials: FJ
authors.lastname: Heidgen
authors.forename: Dominik
authors.initials: D
authors.lastname: Wolf
authors.forename: Thomas
authors.initials: T
authors.lastname: Bieber
authors.forename: Joerg
authors.initials: J
authors.lastname: Wenzel
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D009570:Nitriles; D011087:Polycythemia Vera / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines
chemical_list: D000893:Anti-Inflammatory Agents; D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D053612:Janus Kinases